首页 | 本学科首页   官方微博 | 高级检索  
     

四君子汤对吡柔比星膀胱灌注毒副作用改善的观察
引用本文:胡佩胜,刘晋峰,姚永军,陈晓鹏,米振国. 四君子汤对吡柔比星膀胱灌注毒副作用改善的观察[J]. 基层医学论坛, 2010, 14(16): 493-494
作者姓名:胡佩胜  刘晋峰  姚永军  陈晓鹏  米振国
作者单位:山西红十字泌尿医院,山西,太原,030024
摘    要:目的探讨四君子汤对膀胱肿瘤患者术后吡柔比星膀胱灌注毒副作用的影响。方法随机将40例膀胱肿瘤术后患者分为2组:单纯膀胱灌注组和联合治疗组。单纯膀胱灌注组采用吡柔比星,联合治疗组在吡柔比星膀胱灌注基础上联合四君子汤治疗。结果联合治疗组毒副作用发生率(55.00%)和单纯膀胱灌注组毒副作用发生率(95.00%)比较有明显差异(P〈0.05);联合治疗组肿瘤复发率(15.00%)和单纯膀胱灌注组肿瘤复发率(25.00%)比较无明显差异(P〉0.05)。结论中药四君子汤可以明显地降低肿瘤患者术后吡柔比星膀胱灌注的毒副作用。

关 键 词:四君子汤  膀胱肿瘤  吡柔比星  膀胱灌注

Effect of SiJunZi decoction on intravesical instillation of Pirarubicin
Affiliation:Hu Peisheng,Liu Jinfeng,Yao Yongjun,et al.(The Red Crossed Urology Hospital of Shanxi,Taiyuan,Shanxi 030024 )
Abstract:Objective To investigate the effect of intravesical instillation of pirarubicin plus traditiona1 Chinese medicine SiJunZi Decoction with postoperative patients on advanced bladder cancer.Methods Forty postoperative patients with bladder cancer were randomly assigned into two groups.20 patients in the combined treated were given SJZD and intravesical instillation of pirarubicin;the other group were given intravesical instillation of pirarubicin alone.Results The predominant adverse reactions rate was 50.00%in SJZD plus intravesical instillation of pirarubicin group and 95.00%in intravesical instillation of pirarubicin group,It was significantly lower in the former group than in the latter group(P〈0.05).and the recurrence rate of bladder cancer was 20.00%in intravesical instillation of pirarubicin group and 16.67%in SJZD plus intravesical instillation ofpirarubicin group,No significant difference between them(P〉0.05).Conclusion SJZD was safe and effective in preventing the predominant adverse reactions produced by intravesical instillation of pirarubicin.
Keywords:SiJunZi decoction Bladder cancer Pirarubicin Intravesical instillation
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号